Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Shares Acquired by Assetmark Inc.

Assetmark Inc. lifted its holdings in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 168.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,962 shares of the real estate investment trust’s stock after buying an additional 1,231 shares during the quarter. Assetmark Inc.’s holdings in Sabra Health Care REIT were worth $37,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. grew its holdings in shares of Sabra Health Care REIT by 2.5% in the 1st quarter. Vanguard Group Inc. now owns 34,972,611 shares of the real estate investment trust’s stock worth $516,545,000 after acquiring an additional 838,654 shares during the period. Principal Financial Group Inc. lifted its holdings in shares of Sabra Health Care REIT by 0.8% during the 3rd quarter. Principal Financial Group Inc. now owns 21,573,436 shares of the real estate investment trust’s stock worth $401,479,000 after acquiring an additional 167,069 shares during the period. Janus Henderson Group PLC increased its holdings in shares of Sabra Health Care REIT by 2.9% during the 1st quarter. Janus Henderson Group PLC now owns 5,199,682 shares of the real estate investment trust’s stock worth $76,701,000 after buying an additional 145,548 shares during the last quarter. LSV Asset Management increased its position in Sabra Health Care REIT by 2.5% during the 2nd quarter. LSV Asset Management now owns 4,380,815 shares of the real estate investment trust’s stock worth $67,465,000 after purchasing an additional 104,800 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in shares of Sabra Health Care REIT by 3.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,394,562 shares of the real estate investment trust’s stock valued at $52,275,000 after acquiring an additional 124,825 shares during the period. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Health Care REIT Price Performance

NASDAQ SBRA opened at $18.11 on Tuesday. Sabra Health Care REIT, Inc. has a 1 year low of $12.83 and a 1 year high of $20.03. The stock’s 50-day moving average price is $18.61 and its two-hundred day moving average price is $16.60. The company has a market cap of $4.28 billion, a PE ratio of 44.17, a PEG ratio of 2.28 and a beta of 1.25. The company has a current ratio of 4.16, a quick ratio of 4.16 and a debt-to-equity ratio of 0.90.

Sabra Health Care REIT (NASDAQ:SBRA) last released its quarterly earnings data on Thursday, October 31st. The real estate investment trust reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.35 by ($0.22). Sabra Health Care REIT had a net margin of 14.20% and a return on equity of 3.51%. The company had revenue of $178.00 million during the quarter, compared to analyst estimates of $177.19 million. During the same quarter in the prior year, the company posted $0.34 EPS. On average, analysts predict that Sabra Health Care REIT, Inc. will post 1.39 EPS for the current year.

Sabra Health Care REIT Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 29th. Investors of record on Friday, November 15th will be given a dividend of $0.30 per share. The ex-dividend date is Friday, November 15th. This represents a $1.20 annualized dividend and a dividend yield of 6.63%. Sabra Health Care REIT’s dividend payout ratio is presently 292.68%.

Analyst Ratings Changes

A number of research firms have recently issued reports on SBRA. Citigroup upgraded shares of Sabra Health Care REIT from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $17.00 to $20.00 in a research note on Friday, September 13th. Wells Fargo & Company upgraded shares of Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $16.00 to $20.00 in a research report on Tuesday, October 1st. Scotiabank increased their target price on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “sector perform” rating in a research report on Friday, October 11th. Finally, Truist Financial boosted their target price on Sabra Health Care REIT from $16.00 to $18.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. One analyst has rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $18.71.

About Sabra Health Care REIT

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.